Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2021

View Archived Issues

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Researchers identify markers of adrenomyeloneuropathy severity

NN-1213 lowers appetite and body weight in animal models of obesity

IL-33, a potential new therapeutic target for diabetic kidney disease

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Jiangsu Simcere Pharmaceutical presents new SERDs

Novartis and collaborators describe new antiviral compounds

New HIF-2alpha inhibitors discovered at NiKang Therapeutics

Intarcia Therapeutics identifies new neuropeptide Y receptor agonists

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Edigene and University of Wisconsin-Madison collaborate on in vivo RNA editing therapies

CN Bio and iiCON partner to validate novel organ-on-a-chip infection models for COVID-19

New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations

Spiny mice can regenerate damaged kidneys without fibrosis

HDAC8 targeting for treating AKI shows promise

Cellaria announces new products for modeling tumor microenvironment

Frequency Therapeutics unveils new research program for hearing loss and MS

Massachusetts General Hospital to conduct preclinical trial of Angany's BP/AH-01 for peanut allergy

synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells

Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...